Teriparatide
Who holds supplier records for Teriparatide? 13 organisations hold a current record for Teriparatide: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: China (4), India (3), United States (1), Germany (1) and 1 other country (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Teriparatide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/teriparatide
Reading the evidence
- 13 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (13)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Teriparatide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Hybio Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 36502, 34388 · latest filing Dec 2021
- Alembic Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 38923 · latest filing Sept 2023
- AMBIO INCUnited StatesActive DMF 28464 · latest filing Jun 2017
- Amphastar Nanjing PharmaceuticalsChinaActive DMF 33857 · latest filing May 2019
- AURO PEPTIDES LTDActive DMF 33079 · latest filing Aug 2018
- CHENGDU SHENGNUO BIOPHARM CO LTDChinaActive DMF 32144 · latest filing Feb 2019
- HARBIN JIXIANGLONG BIOTECH CO LTDActive DMF 40036 · latest filing May 2024
- Hefei Xinzhu Biological Technology Co., Ltd.Active DMF 42224 · latest filing Jun 2025
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 34713 · latest filing Sept 2020
- RICHTER-HELM BIOTEC GMBH AND CO KGGermanyActive DMF 29122 · latest filing Apr 2015
- SCINOPHARM TAIWAN LTDTaiwanActive DMF 33210 · latest filing Jan 2019
- SHENZHEN JYMED TECHNOLOGY CO LTDChinaActive DMF 41169 · latest filing Jan 2025
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 35583 · latest filing Feb 2021
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Teriparatide is a recombinant form of parathyroid hormone used in the treatment of osteoporosis. It works by stimulating bone formation, increasing bone mineral density and maintaining bone structure.
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Parathyroid Hormone Analog
- Chemical structure
- Parathyroid Hormone
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Teriparatide?
13 organisations hold an active US FDA Type II Drug Master File or a CEP for Teriparatide: Hybio Pharmaceutical Co., Ltd. (China), Alembic Pharmaceuticals Limited (India), AMBIO INC (United States), Amphastar Nanjing Pharmaceuticals (China), AURO PEPTIDES LTD, CHENGDU SHENGNUO BIOPHARM CO LTD (China), HARBIN JIXIANGLONG BIOTECH CO LTD and Hefei Xinzhu Biological Technology Co., Ltd., and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Teriparatide Drug Master Files are active?
Hybio Pharmaceutical Co., Ltd. (DMF 36502, 34388), Alembic Pharmaceuticals Limited (DMF 38923), AMBIO INC (DMF 28464), Amphastar Nanjing Pharmaceuticals (DMF 33857), AURO PEPTIDES LTD (DMF 33079), CHENGDU SHENGNUO BIOPHARM CO LTD (DMF 32144), HARBIN JIXIANGLONG BIOTECH CO LTD (DMF 40036) and Hefei Xinzhu Biological Technology Co., Ltd. (DMF 42224) and 5 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Teriparatide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Teriparatide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.